THRD

THRD - Third Harmonic Bio Inc Stock Price, Fair Value and News

$5.38 
Market Closed as of 13 Aug 2025, 04:00 pm ET

THRD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

THRD Price Action

THRD RSI Chart

THRD Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

THRD Valuation

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

THRD Fundamentals

THRD Earnings

THRD Profitability

THRD Investor Care

THRD
Third Harmonic Bio, Inc., a biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was incorporated in 2019 and is headquartered in Cambridge, Massachusetts.
 CEO
 WEBSITEthirdharmonicbio.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES31